BeStock  
Stocks › Biotechnology › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2271Biotechnology
$21.73 −$0.98 (-4.32%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $22.00 +1.24%
Open$22.11
Prev close$22.71
Day range$21.63 – $23.05
Volume1.74M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$78.12M-655.1% YoY
Net profit-$68.39M-530.6% YoY
Diluted EPS-$0.39-400.0% YoY
Free cash flow-$37.20M-19.6% YoY
Operating cash flow-$37.14M

Revenue, last 8 quarters

$4.1MDec '24$5.4MMar '25$3.2MJun '25$53.8MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-37.7MDec '24$-39.9MMar '25$-38.9MJun '25$15.9MSep '25$-38.7MDec '25$-45.5MMar '26$-55.3MJun '26$-68.4MSep '26

Diluted EPS by quarter

-0.35Dec '24-0.36Mar '25-0.35Jun '250.13Sep '25-0.29Dec '25-0.32Mar '26-0.37Jun '26-0.39Sep '26

Free cash flow by quarter

$-36.8MDec '24$-41.7MMar '25$-37.1MJun '25$-31.1MSep '25$-29.9MDec '25$-44.4MMar '26$-38.9MJun '26$-37.2MSep '26

Annual revenue

$7.7MFY20$37.0MFY21$24.9MFY22$36.5MFY23$42.1MFY24$62.4MFY25

Profitability & balance sheet

Return on equity-36.5%
Return on assets-33.5%
Return on invested capital-36.9%
Current ratio39.45
Liabilities / assets5.2%
Cash & investments$977.50M
Total debt$28.12M
Net cash (debt)$949.38M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $0.00 $62.38M $0.00
Total Operating Revenue $0.00 $0.00 $0.00 $62.38M $0.00
Operating Expense $78.12M $59.79M $48.77M $173.67M $41.86M
Selling and Admin Expenses $29.19M $22.59M $15.24M $41.51M $9.76M
-General & Admin Expense $29.19M $22.59M $15.24M $41.51M $9.76M
Research & Development $48.93M $37.20M $33.53M $132.17M $32.10M
Operating Profit -$78.12M -$59.79M -$48.77M -$111.29M -$41.86M
Net Non-Operating Interest Income (Expense) $7.15M $3.72M $2.18M $5.63M $1.68M
Non-Operating Interest Income $7.15M $3.72M $2.18M $5.63M $1.68M
Other Income (Expense) $2.57M $722,000.00 $1.08M $4.07M $1.38M
Other Non-Operating Income (Expenses) $2.57M $722,000.00 $1.08M $4.07M $1.38M
Pretax Profit -$68.39M -$55.34M -$45.51M -$101.59M -$38.80M
Tax $0.00 $1,000.00 $1,000.00 $4,000.00 -$55,000.00
Net Profit -$68.39M -$55.34M -$45.51M -$101.59M -$38.75M
Profit from Continuing Operations -$68.39M -$55.34M -$45.51M -$101.59M -$38.75M
Net Income to Parent Company -$68.39M -$55.34M -$45.51M -$101.59M -$38.75M
Net Income to Common Stockholders -$68.39M -$55.34M -$45.51M -$101.59M -$38.75M
Basic EPS -$0.39 -$0.37 -$0.32 -$0.87 -$0.29
Diluted EPS -$0.39 -$0.37 -$0.32 -$0.87 -$0.29

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.03B $1.07B $435.79M $398.69M $398.69M
Total Current Assets $992.67M $1.03B $392.33M $353.76M $353.76M
Cash and Cash Equivalents & Short-Term Investments $977.50M $1.01B $379.84M $343.14M $343.14M
-Cash and Cash Equivalents $86.84M $345.56M $157.83M $112.28M $112.28M
-Short Term Investments $890.67M $668.43M $222.01M $230.86M $230.86M
Restricted Cash $0.00 $0.00 $0.00 $428,000.00 $428,000.00
Other Current Assets $15.16M $17.68M $12.49M $10.19M $10.19M
Total Non-Current Assets $40.80M $42.21M $43.47M $44.93M $44.93M
Net PPE $38.41M $39.76M $41.03M $42.49M $42.49M
-Gross PPE $50.09M $51.04M $51.97M $53.03M $53.03M
-Accumulated Depreciation -$11.68M -$11.29M -$10.94M -$10.54M -$10.54M
Other Non-Current Assets $2.39M $2.45M $2.43M $2.44M $2.44M
Total Liabilities $53.29M $49.35M $44.29M $52.51M $52.51M
Total Current Liabilities $25.16M $20.30M $14.33M $21.68M $21.68M
Payables $1.65M $1.81M $2.43M $1.18M $1.18M
-Accounts Payable $1.65M $1.81M $2.43M $1.18M $1.18M
Current Accrued Expenses $18.20M $12.71M $7.51M $16.47M $16.47M
Short-Term Debt and Capital Lease Obligation $3.06M $2.94M $2.83M $2.74M $2.74M
-Current Capital Lease Obligation $3.06M $2.94M $2.83M $2.74M $2.74M
Other Current Liabilities $2.26M $2.83M $1.56M $1.29M $1.29M
Total Non-Current Liabilities $28.12M $29.05M $29.96M $30.83M $30.83M
Long Term Debt and Capital Lease Obligation $28.12M $29.05M $29.96M $30.83M $30.83M
-Long Term Capital Lease Obligation $28.12M $29.05M $29.96M $30.83M $30.83M
Convertible preferred securities $0.00 $0.00 $0.00 $0.00 $0.00
Total Equity $980.17M $1.02B $391.51M $346.18M $346.18M
Stockholders' Equity $980.17M $1.02B $391.51M $346.18M $346.18M
Capital Stock $169,000.00 $168,000.00 $144,000.00 $136,000.00 $136,000.00
-Common Stock $169,000.00 $168,000.00 $144,000.00 $136,000.00 $136,000.00
Additional Paid-In Capital $1.76B $1.73B $1.04B $948.97M $948.97M
Retained Earnings -$772.40M -$704.01M -$648.67M -$603.15M -$603.15M
Gains/Losses Not Affecting Retained Earnings -$4.51M -$633,000.00 -$115,000.00 $224,000.00 $224,000.00
Current Deferred Liabilities – – – $0.00 $0.00
Non-Current Deferred Liabilities – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$37.14M -$38.87M -$44.36M -$138.89M -$29.72M
Net cash flow from continuing operations -$37.14M -$38.87M -$44.36M -$138.89M -$29.72M
Net Income from Continuing Operations -$68.39M -$55.34M -$45.51M -$101.59M -$38.75M
Depreciation & Depletion & Amortization $420,000.00 $425,000.00 $463,000.00 $2.28M $479,000.00
Other Non-Cash Items $1.01M $970,000.00 $993,000.00 $3.88M $939,000.00
Change in Working Capital $7.12M -$866,000.00 -$9.98M -$67.20M $2.40M
-Change in Prepaid Assets $2.52M -$5.19M -$2.30M -$1.76M $350,000.00
-Change in Payables and Accrued Expense $5.35M $5.14M -$6.91M $279,000.00 $3.26M
-Change in Other Current Assets $66,000.00 -$19,000.00 $10,000.00 -$299,000.00 -$13,000.00
-Change in Other Current Liabilities -$813,000.00 -$797,000.00 -$781,000.00 -$3.03M -$1.19M
Net cash flow from investing -$223.98M -$445.97M $9.64M -$40.87M -$135.72M
Net Cash Flow from Continuing Investing Activities -$223.98M -$445.97M $9.64M -$40.87M -$135.72M
Net PPE Purchase and Sale -$77,000.00 $20,000.00 $2,000.00 -$1.05M -$222,000.00
Net Investment Purchase and Sale -$223.91M -$445.99M $9.63M -$39.82M -$135.50M
Financing Cash Flow $2.40M $672.57M $79.85M $222.50M $219.38M
Net Cash Flow from Continuing Financing Activities $2.40M $672.57M $79.85M $222.50M $219.38M
Net Common Stock Issuance $0.00 $652.04M $62.78M $212.40M $212.40M
Proceeds from Stock Option Exercised $3.05M $20.62M $17.61M $10.14M $7.01M
Net Other Financing Charges -$643,000.00 -$95,000.00 -$537,000.00 -$36,000.00 –
Ending Cash Balance $88.97M $347.70M $159.97M $114.85M $114.85M
Net Change in Cash -$258.72M $187.73M $45.12M $42.75M $53.94M
Beginning Cash Balance $347.70M $159.97M $114.85M $72.10M $60.91M
Free Cash Flow -$37.20M -$38.87M -$44.36M -$139.93M -$29.94M
-Change in Receivables – – – $0.00 –
-Change In Other Working Capital – – – -$62.38M $0.00

Discussion

No comments yet — be the first to weigh in on TNGX.

Sign in to join the discussion.

Scroll to Top